Rubicon Research Limited
Promoter holding in Rubicon Research Limited was 59.76% in Jun 2026, down 0.10 points from the previous quarter. Since Sep 2025 it has fallen 0.23 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 59.76%▼0.10 | 40.24%▲0.10 |
| Mar '26 | 59.86%▼0.13 | 40.14%▲0.13 |
| Dec '25 | 59.99%=0.00 | 40.01%=0.00 |
| Sep '25 | 59.99% | 40.01% |
Trend
- Of the last 3 quarterly changes on record, promoter holding fell in 2 and stayed the same in 1.
- The largest quarterly change was a fall of 0.13 points in the quarter to Mar 2026.
Compared with similar companies
Promoter holding in Rubicon Research Limited is higher than 59% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Rubicon Research Limited | 59.76% |
| Neuland Laboratories Limited | 32.62% |
| Piramal Pharma Limited | 34.80% |
| Granules India Limited | 37.39% |
| Sagility Limited | 50.95% |
| Inventurus Knowledge Solutions Limited | 63.72% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Rubicon Research Limited's promoter holding?
Promoters held 59.76% of Rubicon Research Limited as of 30 Jun 2026, and the public held 40.24%.
Has Rubicon Research Limited's promoter holding increased?
No, it fell by 0.10 percentage points in the quarter to Jun 2026.
Are any promoter shares of Rubicon Research Limited pledged?
No promoter shares are recorded as pledged.
How does Rubicon Research Limited's promoter holding compare with similar companies?
Promoter holding in Rubicon Research Limited is higher than 59% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.